|
|
GovernmentDocs 5/5/2008 | 0 (0) | 18 | 0 | 0 | English
Pharmacogenomics, Personalized Medicine and the Role of FDABio-IT World Conference Hynes... variability in drug response FDA initiatives to facilitate innovation including pharmacogenomics (PGx ... more>>
FDADocs 5/9/2008 | 0 (0) | 15 | 0 | 0 | English
BY EITHER OR BOTH FDA AND USDA. IT DOES NOT COVER PRODUCTS MADE FOR ON-SITE CONSUMPTION SUCH AS... JURISDICTION. FDA JURISDICTION 21 USC 392(b) Meats and meat food products shall be exempt from the ... more>>
FDADocs 5/5/2008 | 0 (0) | 13 | 0 | 0 | English
. Department of Health and Human Services Food and Drug AdministrationMEDWATCHFORM FDA 3500A (10/05)A...Page ____ of ____Mfr Report # UF/Importer Report #FDA Use OnlyC. SUSPECT PRODUCT(S ... more>>
FDADocs 5/5/2008 | 0 (0) | 20 | 0 | 0 | English
Nomination and Approval of CBER Inspectors and Product Specialists Assigned to Conduct Inspections of Biological Products SOPP 8505 APPENDIX 1Instructions for completing FDA Form 2115, Credential ... more>>
FDADocs 5/9/2008 | 0 (0) | 14 | 0 | 0 | English
NDA 21-877 Nelarabine Errata Please replace Tables 19, 20, 28 and 29 in the FDA Briefing Document with the following Tables Table 1: Transplantation of Pediatric CR and CR* patients Stratum 01 650 mg ... more>>
FDADocs 5/9/2008 | 0 (0) | 37 | 0 | 0 | English
Lessons to Be Learned: The FDA ExperienceJean Temeck, M.D.Medical Team LeaderPediatric and...: Additional Safeguards for Children in Clinical Investigations of FDA-regulated products ... more>>
FDADocs 5/9/2008 | 0 (0) | 18 | 0 | 0 | English
,1\.AviagenNorthAmerica ParkA6agenDr. Lester Crawford, Acting Director Food and Drug Administration 5600 FishersLane. Rm. I47 1 Mail Stop HF- I Rockville, MD 2085... ... more>>
FDADocs 5/9/2008 | 0 (0) | 20 | 0 | 0 | English
ERRATA TO FDA BRIEFING DOCUMENT1.The following items in the briefing document need to be corrected. Deletions are indicated by strikethrough and corrections are in italics.??? ???Page ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 43 | 2 | 0 | English
Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLPDocument issued on: June 2004U.S. Department of Health and Human Services Food and Drug ... more>>
FDADocs 5/9/2008 | 0 (0) | 39 | 0 | 0 | English
Session IIIDrug ShortagesIndustry Perspective FDA/CDER Drug Shortage website Oncology Times articleDrug Shortages in Pediatric OncologyMarch 2006 ODACWayne Rackoff, M.D.Johnson ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 43 | 0 | 0 | English
Draft Guidance for Industry and FDA Staff Establishing the Performance Characteristics of In Vitro Diagnostic Devices for the Detection or Detection and Differentiation of Influenza VirusesDRAFT ... more>>
FDADocs 5/9/2008 | 0 (0) | 36 | 0 | 0 | English
DISTRICT ADDRESS AND PHONE NO.DEPARTMENT OF HEALTH AND HUMAN SERVICESFOOD AND DRUG ADMINISTRATIONNAME AND TITLE OF INDIVIDUAL300 S. Riverside Plaza, Suite 550 South Chi... ... more>>
FDADocs 5/9/2008 | 0 (0) | 61 | 2 | 0 | English
Judy Staffa, co-leads, presiding. PRESENT: SOLOMON IYASU JUDY STAFFA LANA PAULS GERALD DAL PAN FDA FDA ... more>>
FDADocs 5/5/2008 | 0 (0) | 29 | 4 | 0 | English
Cell Therapy and FDA RegulationCelia M.Witten, Ph.D., M.D. Director, Office of Cellular, Tissue, and Gene Therapies Mid-Atlantic Bio October 25, 2007 Bethesda, MarylandOutline ... more>>
FDADocs 5/9/2008 | 0 (0) | 26 | 0 | 0 | English
/FDA/ORA/HQ/OE/DEIO Building PKLN Room RM1490 (Mail stop HFC-1) Rockville MD 20857 Dear Sir: We are aware that the FDA has undertaken a 60-day review of various forms of labels, tags and tamper evident ... more>>
| | | |
| results / page 15/25/50 |
Page: 6 of 33
|
...6...
|
|